hyaluronoglucosaminidase has been researched along with Immunologic Deficiency Syndromes in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bilic, I; Brachtl, G; Gangadharan, B; Haider, N; Höfinghoff, J; Leidenmühler, P; Weiller, M | 1 |
| Wasserman, RL | 2 |
| Sanford, M | 1 |
| Church, J; Engl, W; Gelmont, D; Grant, AJ; Gupta, S; Kobrynski, L; Leibl, H; Melamed, I; Puck, J; Ratnayake, A; Richmond, WG; Rubinstein, A; Sharkhawy, M; Stein, MR; Wasserman, RL; Yel, L | 1 |
| Doralt, J; Engl, W; Gelmont, D; Gupta, S; Kobrynski, L; Leibl, H; Melamed, I; Puck, J; Sharkhawy, M; Wasserman, RL; Yel, L | 1 |
| Empson, VG; Engl, W; Gelmont, D; Gupta, S; Leibl, H; McCoy, B; Melamed, I; Puck, J; Schiff, RI; Stein, MR; Wasserman, RL | 1 |
| Sharova, NM; Suchkov, SV; Suchkova, TN | 1 |
4 review(s) available for hyaluronoglucosaminidase and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases.
Topics: Animals; Humans; Hyaluronoglucosaminidase; Immunoglobulins; Immunologic Deficiency Syndromes; Immunotherapy; Infusions, Subcutaneous; Practice Guidelines as Topic; Recombinant Proteins | 2017 |
Human immunoglobulin 10 % with recombinant human hyaluronidase: replacement therapy in patients with primary immunodeficiency disorders.
Topics: Animals; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunoglobulins; Immunologic Deficiency Syndromes; Infusions, Intravenous; Infusions, Subcutaneous; Injections, Subcutaneous; Recombinant Proteins | 2014 |
A new subcutaneous immune globulin (HyQvia) for primary immunodeficiency.
Topics: Animals; Clinical Trials as Topic; Humans; Hyaluronoglucosaminidase; Immunoglobulin G; Immunologic Deficiency Syndromes; Injections, Subcutaneous; Recombinant Proteins | 2015 |
Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back again.
Topics: Clinical Trials, Phase III as Topic; gamma-Globulins; Humans; Hyaluronoglucosaminidase; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Deficiency Syndromes; Infusions, Intravenous; Infusions, Subcutaneous; Injections, Intramuscular; Patient Satisfaction; Quality of Life; Recombinant Proteins | 2012 |
3 trial(s) available for hyaluronoglucosaminidase and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Female; Hospitalization; Humans; Hyaluronoglucosaminidase; Immunoglobulins, Intravenous; Immunologic Deficiency Syndromes; Infusions, Subcutaneous; Male; Middle Aged; Recombinant Proteins; Time Factors; Treatment Outcome; Young Adult | 2016 |
Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability.
Topics: Adolescent; Antigens, Neoplasm; Child; Child, Preschool; Female; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Immunoglobulins; Immunologic Deficiency Syndromes; Injections, Subcutaneous; Male; Recombinant Proteins; Time Factors; United States | 2016 |
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Humans; Hyaluronoglucosaminidase; Immunoglobulins; Immunologic Deficiency Syndromes; Infusions, Subcutaneous; Middle Aged; Prospective Studies; Recombinant Proteins | 2012 |
2 other study(ies) available for hyaluronoglucosaminidase and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins.
Topics: Animals; Humans; Hyaluronoglucosaminidase; Immunoglobulins; Immunologic Deficiency Syndromes; Infusions, Subcutaneous; Injections, Subcutaneous; Swine | 2023 |
[A clinico-immunological assessment of the efficacy of combined methods of treating patients with different immunopathological forms of focal scleroderma].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Autoimmune Diseases; Chronic Disease; Combined Modality Therapy; Evaluation Studies as Topic; Female; Humans; Hyaluronoglucosaminidase; Immunologic Deficiency Syndromes; Male; Middle Aged; Penicillins; Peptides; Scleroderma, Localized; Thymus Extracts | 1990 |